NM_033409.4:c.1371C>G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PP3_ModerateBS1_SupportingBS2

The NM_033409.4(SLC52A3):​c.1371C>G​(p.Phe457Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000671 in 1,610,086 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 3 hom. )

Consequence

SLC52A3
NM_033409.4 missense

Scores

7
8
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8O:2

Conservation

PhyloP100: 2.78

Publications

11 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.858
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000453 (69/152358) while in subpopulation NFE AF = 0.000882 (60/68032). AF 95% confidence interval is 0.000703. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033409.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
NM_033409.4
MANE Select
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5NP_212134.3
SLC52A3
NM_001370085.1
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6NP_001357014.1Q9NQ40-1
SLC52A3
NM_001370086.1
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6NP_001357015.1Q9NQ40-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
ENST00000645534.1
MANE Select
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5ENSP00000494193.1Q9NQ40-1
SLC52A3
ENST00000217254.11
TSL:5
c.1371C>Gp.Phe457Leu
missense
Exon 6 of 6ENSP00000217254.7Q9NQ40-1
SLC52A3
ENST00000488495.3
TSL:3
c.1371C>Gp.Phe457Leu
missense
Exon 5 of 5ENSP00000494009.1Q9NQ40-1

Frequencies

GnomAD3 genomes
AF:
0.000453
AC:
69
AN:
152240
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000374
AC:
89
AN:
237784
AF XY:
0.000353
show subpopulations
Gnomad AFR exome
AF:
0.0000709
Gnomad AMR exome
AF:
0.0000589
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000492
Gnomad NFE exome
AF:
0.000789
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.000694
AC:
1011
AN:
1457728
Hom.:
3
Cov.:
30
AF XY:
0.000639
AC XY:
463
AN XY:
724978
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33394
American (AMR)
AF:
0.0000449
AC:
2
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39468
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85692
European-Finnish (FIN)
AF:
0.0000964
AC:
5
AN:
51892
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5728
European-Non Finnish (NFE)
AF:
0.000872
AC:
969
AN:
1110768
Other (OTH)
AF:
0.000532
AC:
32
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000453
AC:
69
AN:
152358
Hom.:
0
Cov.:
32
AF XY:
0.000416
AC XY:
31
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41588
American (AMR)
AF:
0.000131
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000882
AC:
60
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000672
Hom.:
0
Bravo
AF:
0.000427
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000231
AC:
1
ESP6500EA
AF:
0.000710
AC:
6
ExAC
AF:
0.000290
AC:
35

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
2
-
Brown-Vialetto-van Laere syndrome 1 (4)
-
1
-
Inborn genetic diseases (1)
-
1
-
not specified (1)
-
1
-
Progressive bulbar palsy of childhood;C0796274:Brown-Vialetto-van Laere syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Uncertain
0.095
D
BayesDel_noAF
Pathogenic
0.28
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.074
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.77
T
M_CAP
Uncertain
0.16
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Uncertain
0.20
D
MutationAssessor
Pathogenic
3.3
M
PhyloP100
2.8
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.78
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.012
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.95
Gain of helix (P = 0.0696)
MVP
0.80
MPC
1.1
ClinPred
0.76
D
GERP RS
1.9
Varity_R
0.86
gMVP
0.82
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145431028; hg19: chr20-741709; API